The ENETS consensus guidelines for the management of pancreatic NET's recommend testing for MEN1 in patients presenting with insulinoma before the age of 20, in addition to testing of patients with multiple pancreatic NET's at any age (51). This evidence concerns the gene MEN1 and pancreatic neuroendocrine tumor.